WEBVTT

00:00:00.567 --> 00:00:03.690
Retatrutide and tirzepatide sound similar.

00:00:03.977 --> 00:00:06.568
But if you are comparing them, three details

00:00:06.481 --> 00:00:08.899
matter more than the biggest weight loss number

00:00:08.812 --> 00:00:09.685
in a headline.

00:00:10.458 --> 00:00:14.861
Tirzepatide acts on GIP and GLP one receptors.

00:00:15.160 --> 00:00:18.631
Retatrutide also targets the glucagon receptor.

00:00:18.943 --> 00:00:21.974
That makes it a triple agonist, not simply

00:00:21.887 --> 00:00:24.199
a stronger version of the same medicine.

00:00:24.981 --> 00:00:28.904
As checked in September twenty twenty-six, Lilly describes

00:00:28.817 --> 00:00:32.700
retatrutide as investigational and available only in its

00:00:32.613 --> 00:00:36.856
clinical trials. Tirzepatide has approved medicines in some

00:00:36.769 --> 00:00:40.226
markets. Local authorization still matters.

00:00:40.976 --> 00:00:43.287
To compare two weight loss headlines, look at

00:00:43.187 --> 00:00:46.005
the people, the length of treatment and how

00:00:45.905 --> 00:00:47.324
the result was calculated.

00:00:47.623 --> 00:00:49.708
Separate trials do not tell you what the

00:00:49.621 --> 00:00:52.732
same person would experience on both treatments.

00:00:53.490 --> 00:00:55.575
If you are searching in Bali, a product

00:00:55.488 --> 00:00:58.625
listing alone does not establish an approved medicine.

00:00:58.952 --> 00:01:02.209
Ask for the exact product name, manufacturer and

00:01:02.202 --> 00:01:05.938
local registration details before treating two offers as

00:01:05.852 --> 00:01:06.564
comparable.

00:01:07.334 --> 00:01:10.391
The article below explains the differences and gives

00:01:10.304 --> 00:01:12.376
you a short question list to take into

00:01:12.289 --> 00:01:13.828
a weight management appointment.

00:01:14.141 --> 00:01:16.638
Start with the treatment goal and the available

00:01:16.552 --> 00:01:17.331
options.